FULGENT GENETICS, INC. Other Current Assets
FULGENT GENETICS, INC. (FLGT) had Other Current Assets of $22.23 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-07-30
- 2026-06-30: Other Assets, Current $22.23M.
- 2026-03-31: Other Assets, Current $24.30M.
- 2025-12-31: Other Assets, Current $22.55M.
- 2025-09-30: Other Assets, Current $60.38M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $22.23M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $24.30M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $22.55M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $60.38M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $58.61M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $24.98M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $23.02M 10-K · filed 2026-02-27 | $26.44M 10-K · filed 2025-02-28 |
| 2024-09-30 | $56.16M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $30.82M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $28.75M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $32.56M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $32.78M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $35.05M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $32.69M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $48.89M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $21.39M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $26.48M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $19.96M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $22.55M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $32.03M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $34.32M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $32.85M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $40.39M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $30.00M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $6.36M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $3.32M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $2.25M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $1.79M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $2.27M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $2.31M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.56M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $2.37M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $2.54M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $2.62M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $2.44M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $2.40M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.67M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.20M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $906.00K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $4.88M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $314.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |